申请人:PIERRE Fabrice
                            
                            
                                公开号:US20100298302A1
                            
                            
                                公开(公告)日:2010-11-25
                            
                            The invention provides compounds that inhibit selected kinases (Pim, Flt and/or CK2 kinases) and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain infections and immunological disorders.
                            本发明提供了抑制选择性激酶(Pim、Flt和/或CK2激酶)的化合物和含有这些化合物的组合物。这些化合物和组合物对于治疗增殖性疾病,如癌症,以及其他与激酶相关的疾病包括炎症、疼痛、某些感染和免疫性疾病非常有用。